Updated posts 2026
The Prostate Cancer Foundation (PCF) recently held its annual Pro-Am Tennis & Golf Tournament in South Florida, marking another successful chapter in the fight against prostate cancer. The event, spanning five days, seamlessly blended the 2024 Milken Institute South Florida Dialogues with the PCF Pro-Am Tournaments, creating an engaging platform for advocacy and philanthropy.
The festivities commenced with the Milken Institute South Florida Dialogues in Palm Beach, featuring insightful discussions and the much-anticipated PCF Pro-Am Tennis Tournament. The event reached its pinnacle with a Gala Dinner at the historic Henry Morrison Flagler Museum, honoring the remarkable contributions of individuals like John and Daria Becker Barry and the Barry Family. The evening was enriched with captivating performances by renowned mentalist Oz Pearlman and a musical showcase by Pat Benatar & Neil Giraldo.
The roster of distinguished attendees included luminaries from various spheres, such as finance, philanthropy, and entertainment. Among them were Mike Milken, Bill Koch, Monica Seles, and many others, underscoring the widespread support for PCF’s mission.
Generous benefactors contributed significantly to the success of the Palm Beach event, demonstrating their unwavering commitment to advancing cancer research. Their support enabled PCF to continue funding groundbreaking initiatives aimed at prevention, detection, and treatment.
Michael Milken, John Barry, Daria Becker Barry, Charles J. Ryan
Throughout the event, guests were treated to a series of intimate salons, delving into topics akin to those discussed at the Global Conference. These sessions provided invaluable insights and fostered meaningful conversations among participants.
Central to the event’s purpose were the PCF Pro-Am Tennis and Golf Tournaments, where athletes and spectators alike converged for a day of spirited competition. Following intense matches, champions emerged, including Pat Davidson and Janice Aron in Group 1, and Giselle Asplundh and Joe Jacobs in Group 2.
Prostate cancer occupies an unusual position among major cancers: it is the second most commonly diagnosed cancer in men worldwide, yet it attracts markedly less research funding per case than breast or lung cancer. Part of the reason is that most cases progress slowly and many men die with the disease rather than of it, which has historically made it seem less urgent. The clinical difficulty is precisely that distinction — telling the indolent cases from the aggressive ones early enough to matter — and it is where a large share of the research funding described here is directed.
PCF’s impact extends far beyond the tournament grounds. Through initiatives like supporting young investigators, partnering with the VA to enhance care for veterans, and fostering collaborative research teams, PCF continues to drive progress in cancer treatment and beyond. The organization’s focus on immunotherapy, the microbiome, and nutrition science underscores its commitment to pioneering approaches in cancer research.
As the curtains closed on another successful event, the Prostate Cancer Foundation reaffirmed its position as a global leader in cancer research philanthropy. With nearly $800 million allocated to cutting-edge research and a tangible reduction in mortality rates, PCF’s legacy of saving lives and advancing science remains unparalleled. In the relentless pursuit of a world free from prostate cancer, PCF’s unwavering dedication serves as a beacon of hope for millions worldwide.
